Brief: Incyte - Announces Agreement With CMS To Resolve Opzelura Medicaid Rebate Litigation - SEC Filing

Incyte

22/06/2026 12:52

June 22 (Reuters) - Incyte Corp INCY.O:
INCYTE - ANNOUNCES AGREEMENT WITH CMS TO RESOLVE OPZELURA MEDICAID REBATE LITIGATION - SEC FILING
INCYTE - CMS WILL NOT APPLY LINE EXTENSION REGULATION TO OPZELURA; INCYTE WITHDRAWS LAWSUIT - SEC FILING
INCYTE - EXPECTS ONE-TIME NON-CASH BENEFIT OF $246 MILLION IN Q2 ENDING JUNE 30, 2026 - SEC FILING
INCYTE - WILL NO LONGER ACCRUE FOR LINE EXTENSION REGULATIONS FOR OPZELURA; EXPECTS GROSS-TO-NET IMPROVEMENT - SEC FILING
INCYTE - PLANS TO UPDATE FINANCIAL GUIDANCE TO REFLECT SETTLEMENT IMPACT AT NEXT EARNINGS RELEASE - SEC FILING
INCYTE: SETTLEMENT WAS REACHED BASED ON THE UNIQUE FACTS OF OPZELURA AND JAKAFI
Source text: [ID:n0000879169-26-000046]
Further company coverage: INCY.O

 ((Reuters.Briefs@thomsonreuters.com;))